PEN Stock Cash Flow Statements

Penumbra Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Penumbra Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31

cash flows from operating activities:
net income	45,270,000	39,223,000	33,683,000	29,527,000	-60,200,000	11,002,000	54,218,000	9,214,000	18,960,000	8,562,000													9,301,000	11,000,000	16,249,000	10,454,000			13,381,000	5,491,000	9,083,000	238,000	-1,558,000	-3,106,000	14,955,000	-1,106,000	185,000	780,000	1,633,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	5,507,000	5,015,000	4,388,000	4,148,000	7,647,000	7,519,000	7,039,000	6,933,000	6,710,000	6,575,000	6,441,000	6,225,000	5,929,000	5,726,000	5,753,000	3,633,000	3,551,000	3,471,000	3,458,000	3,343,000	3,131,000	2,959,000	2,314,000	2,053,000	1,933,000	1,804,000	1,709,000	1,511,000	1,549,000	1,399,000	1,201,000	1,158,000	768,000	654,000	488,000	663,000	608,000	538,000	525,000
stock-based compensation	14,234,000	13,785,000	12,095,000	10,940,000	9,560,000	13,569,000	10,791,000	14,136,000	12,823,000	12,766,000	9,997,000	9,702,000	8,786,000	8,893,000	41,662,000	7,903,000	9,803,000	6,395,000	8,055,000	6,238,000	5,559,000	5,689,000	5,014,000	6,241,000	5,135,000	5,095,000	4,871,000	4,412,000	4,985,000	4,154,000	4,720,000	4,487,000	4,593,000	4,012,000	3,837,000	4,263,000	3,522,000	3,015,000	2,145,000
impairment charge			0	0
inventory write-downs	775,000	2,485,000		4,762,000	35,826,000	358,000		3,851,000	390,000	1,009,000		478,000	980,000	593,000		358,000	960,000	991,000		564,000	619,000	1,097,000		1,107,000	1,010,000	658,000		376,000	370,000	300,000
deferred taxes	-6,749,000	-1,998,000	4,600,000	2,797,000	-24,211,000	475,000	-19,026,000	2,415,000	-1,497,000	-953,000	-1,346,000	5,545,000	1,637,000	-4,378,000	-14,900,000	-1,761,000	1,347,000	1,223,000	-2,181,000	-11,397,000	-3,738,000	-1,502,000	1,719,000	1,822,000	-2,799,000	1,078,000	-69,000	1,103,000	-5,305,000	-2,209,000				-1,000	-12,235,000	64,000	-1,536,000	1,329,000
other	191,000	452,000	2,717,000	703,000	922,000	-221,000	-285,000	-964,000	3,447,000	140,000	395,000	1,628,000	263,000	-1,012,000	1,007,000	376,000	423,000	886,000	1,320,000	571,000	2,461,000	168,000	-140,000	-414,000	207,000	396,000	-4,000	-324,000	31,000	357,000	117,000	107,000
changes in operating assets and liabilities:
accounts receivable	-4,782,000	543,000	3,232,000	25,394,000	-10,489,000	8,460,000	6,343,000	1,812,000	-4,881,000	-3,540,000	-12,500,000	-3,058,000	-45,589,000	-8,710,000	-14,381,000	15,935,000	-9,955,000	-12,943,000	-852,000	-14,200,000	6,995,000	-238,000	-3,509,000	-3,968,000	-4,179,000	-13,373,000	-2,478,000	-6,987,000	-10,188,000	-6,109,000	-9,822,000	5,255,000	-2,671,000	-1,880,000	-7,472,000	-2,030,000	-3,715,000	-1,343,000	-3,680,000
inventories	-11,371,000	-10,762,000	-19,666,000	-23,039,000	-11,334,000	-11,619,000	-21,244,000	-20,708,000	-15,117,000	-10,641,000	-12,314,000	-26,266,000	-24,287,000	-11,764,000	-5,742,000	-4,269,000	-9,935,000	-31,608,000	-17,041,000	-8,005,000	-16,845,000	-15,090,000	-13,547,000	-9,339,000	-11,793,000	-6,728,000	-6,893,000	-11,447,000	-4,156,000	208,000	-4,110,000	-7,889,000	-770,000	-6,057,000	-5,719,000	-1,983,000	-2,952,000	-9,083,000	-7,114,000
prepaid expenses and other current and non-current assets	182,000	-96,000	-4,681,000	-407,000	-2,425,000	4,565,000	-8,621,000	-4,387,000	-1,907,000	-3,994,000	721,000	502,000	1,349,000	-3,809,000	-5,936,000	-1,253,000	-2,380,000	-3,463,000	-2,859,000	-1,751,000	-2,711,000	-1,544,000	-613,000	424,000	-3,857,000	45,000	1,498,000	-672,000	-1,581,000	2,986,000	-867,000	400,000	655,000	2,248,000	-3,500,000	-35,000	-2,260,000	-3,248,000	-2,307,000
accounts payable	-3,249,000	-251,000	-1,863,000	543,000	283,000	5,209,000	-957,000	2,313,000	-2,333,000	2,074,000	295,000	4,066,000	7,635,000	1,389,000	-376,000	-500,000	-1,961,000	1,272,000	-79,000	-223,000	-927,000	921,000	2,715,000	2,908,000	1,918,000	-1,503,000	-359,000	1,063,000	3,000	622,000	978,000	580,000	-596,000	889,000	428,000	-383,000	-20,000	1,350,000	-1,369,000
accrued expenses and other non-current liabilities	4,938,000	574,000	13,893,000	1,099,000	87,000	-1,022,000	6,572,000	-1,986,000	504,000	1,131,000	4,377,000	-9,493,000	7,409,000	8,249,000	7,273,000	4,783,000	-3,462,000	8,482,000	-2,827,000	31,186,000	-5,832,000	732,000	-198,000	9,670,000	-1,921,000	6,000	1,402,000	11,190,000	-446,000	2,084,000	654,000	5,094,000	-346,000	4,766,000	-3,023,000	5,361,000	-578,000	4,013,000	2,880,000
net cash from operating activities	44,946,000	48,970,000	51,108,000	56,467,000	22,611,000	38,295,000	36,261,000	30,844,000	17,099,000	13,129,000	1,337,000	-12,909,000	-39,575,000	-4,514,000	-9,270,000	36,450,000	-3,310,000	-14,368,000	-2,083,000	-3,550,000	-21,689,000	-5,920,000	4,767,000	22,050,000	1,903,000	-2,068,000	7,531,000	10,445,000	124,000	10,708,000	-907,000	10,754,000	650,000	2,194,000	-2,756,000	2,504,000	-8,971,000	-3,584,000	-9,648,000
capex	-15,688,000	-11,740,000	-5,308,000	-5,034,000	-4,938,000	-4,008,000	-3,738,000	-3,525,000	-4,655,000	-2,113,000	-3,116,000	-7,560,000	-2,998,000	-3,331,000	-10,601,000	-3,199,000	-3,243,000	-1,807,000	-3,863,000	-3,302,000	-7,755,000	-8,429,000	-8,006,000	-6,282,000	-3,315,000	-1,603,000	-3,381,000	-1,206,000	-1,583,000	-2,396,000	-7,683,000	1,081,000	-2,098,000	-2,855,000	-6,557,000	-1,746,000	-2,354,000	-781,000	-1,024,000
free cash flows	29,258,000	37,230,000	45,800,000	51,433,000	17,673,000	34,287,000	32,523,000	27,319,000	12,444,000	11,016,000	-1,779,000	-20,469,000	-42,573,000	-7,845,000	-19,871,000	33,251,000	-6,553,000	-16,175,000	-5,946,000	-6,852,000	-29,444,000	-14,349,000	-3,239,000	15,768,000	-1,412,000	-3,671,000	4,150,000	9,239,000	-1,459,000	8,312,000	-8,590,000	11,835,000	-1,448,000	-661,000	-9,313,000	758,000	-11,325,000	-4,365,000	-10,672,000
cash flows from investing activities:
purchases of non-marketable investments			0	0	0	-10,000,000
purchases of marketable investments	-1,000	-35,000	-9,884,000	-1,718,000	-41,000	-11,267,000	-8,570,000	-58,176,000							-19,669,000	-74,186,000	-20,673,000	-12,266,000	-33,047,000	-59,694,000			-47,776,000	0
proceeds from maturities of marketable investments	0	13,000,000	4,800,000	42,890,000	39,551,000	43,375,000	36,495,000	18,100,000	13,365,000	14,605,000	12,195,000	16,134,000	23,911,000	20,668,000	23,753,000	30,157,000	48,313,000	19,497,000	25,865,000	15,431,000	14,555,000	12,980,000	12,535,000	27,279,000	17,500,000	33,300,000	24,425,000	24,818,000	34,329,000	43,540,000	39,224,000	37,910,000	20,649,000	15,020,000	18,590,000	43,577,000	-9,246,000	11,750,000
purchases of property and equipment	-15,579,000	-13,467,000	-5,371,000	-5,451,000	-4,536,000	-5,824,000	-3,645,000	-3,332,000	-4,342,000	-3,894,000	-3,562,000	-6,348,000	-4,431,000	-4,957,000	-8,092,000	-5,802,000	-3,295,000	-3,991,000	-3,753,000	-4,153,000	-6,719,000	-10,131,000	-7,984,000	-7,917,000	-3,745,000	-2,463,000	-3,040,000	-1,458,000	-2,282,000	-2,823,000	-5,727,000	-1,441,000	-2,170,000	-3,194,000	-6,557,000	-3,383,000	-2,580,000	-1,115,000	-967,000
net cash from investing activities	-15,580,000	-502,000	-10,955,000	35,721,000	34,474,000	18,384,000	24,280,000	-44,396,000	-6,671,000	10,711,000	8,633,000	9,786,000	20,660,000	15,711,000	-1,339,000	-49,831,000	26,345,000	3,090,000	-10,226,000	-49,416,000	-54,544,000	10,037,000	-43,734,000	14,281,000	-15,113,000	31,855,000	9,625,000	-20,647,000	12,824,000	-2,187,000	-16,394,000	-22,105,000	-27,492,000	-11,662,000	4,207,000	-3,824,000	-1,300,000	1,604,000	-129,400,000
cash flows from financing activities:
proceeds from exercises of stock options	6,704,000	4,022,000	1,090,000	484,000	61,000	238,000	860,000	834,000	1,614,000	2,209,000	1,493,000	1,725,000	3,466,000	1,102,000	2,473,000	1,213,000	312,000	666,000	844,000	3,208,000	791,000	396,000	554,000	1,301,000	1,194,000	1,071,000	770,000	1,123,000	1,843,000	1,328,000	804,000	1,619,000	1,575,000	1,050,000	279,000	1,400,000	1,364,000	129,000	71,000
proceeds from issuance of stock under employee stock purchase plan			6,440,000	0			6,511,000	0			5,768,000	0			6,351,000	0			5,355,000	0			4,205,000	0			3,647,000	0			2,895,000	0			2,795,000	0
payment of employee taxes related to vested stock	-62,000	-445,000		-72,000	-89,000	-421,000		-123,000	-822,000	-204,000		-1,887,000	-1,900,000	-3,181,000		-3,533,000	-3,952,000	-3,036,000		-4,764,000	-1,768,000	-2,105,000
payments of finance lease obligations	-691,000	-613,000	-589,000	-578,000	-559,000	-550,000	-525,000	-499,000	-483,000	-474,000	-452,000	-441,000	-433,000	-425,000	-395,000	-364,000	-355,000	-337,000	-347,000	-95,000	-1,018,000	-1,958,000
net cash from financing activities	14,817,000	2,708,000	6,068,000	-100,554,000	8,274,000	-794,000	5,921,000	212,000	8,694,000	1,376,000	5,735,000	-603,000	9,131,000	-2,641,000	2,961,000	-2,684,000	3,173,000	-2,614,000	2,457,000	-1,651,000	138,461,000	-4,350,000	-502,000	-1,439,000	-5,308,000	-1,710,000	3,168,000	-1,047,000	-5,192,000	-6,744,000	2,445,000	-700,000	-2,910,000	105,524,000	-5,127,000	4,450,000	7,806,000	-3,000	-770,000
effect of foreign exchange rate changes on cash and cash equivalents	1,531,000	474,000	-2,293,000	510,000	-141,000	-257,000	267,000	-70,000	357,000	-386,000	-691,000	336,000	-145,000	228,000	737,000	78,000	437,000	-146,000	-593,000	351,000	-303,000	-90,000	667,000	-572,000	173,000	-321,000	-216,000	-714,000	-856,000	391,000	-128,000	1,096,000	-3,055,000	91,000	1,056,000	-1,188,000	-1,227,000	42,000	267,000
net increase in cash and cash equivalents	45,714,000	51,650,000	43,928,000	-7,856,000	65,218,000	55,628,000	66,729,000	-13,410,000	19,479,000	24,830,000			-9,929,000	8,784,000	-6,911,000	-15,987,000			-10,445,000	-54,266,000	61,925,000	-323,000	-38,802,000	34,320,000	-18,345,000	27,756,000	20,108,000				-14,984,000	-10,955,000	-32,807,000	96,147,000	-2,620,000	1,942,000	-3,692,000	-1,941,000	-139,551,000
cash and cash equivalents—beginning of period	0	324,404,000	0	0	0	167,486,000	0	0	0	69,858,000	0	0	0	59,379,000	0	0	0	69,670,000	0	0	0	72,779,000	0	0	0	67,850,000	0				0	0	0	13,236,000	0	0	0	19,547,000	0
cash and cash equivalents—end of period	45,714,000	376,054,000	43,928,000	-7,856,000	65,218,000	223,114,000	66,729,000	-13,410,000	19,479,000	94,688,000	15,014,000	-3,390,000	-9,929,000	68,163,000	-6,911,000	-15,987,000	26,645,000	55,632,000	-10,445,000	-54,266,000	61,925,000	72,456,000	-38,802,000	34,320,000	-18,345,000	95,606,000	20,108,000				-14,984,000	-10,955,000	-32,807,000	109,383,000	-2,620,000	1,942,000	-3,692,000	17,606,000	-139,551,000
noncash investing and financing activities:
right-of-use assets obtained in exchange for operating lease obligations	1,976,000	838,000	447,000	1,077,000	572,000	292,000	7,853,000	331,000	814,000	341,000	20,784,000	304,000	3,513,000	47,678,000	1,332,000	45,734,000	53,641,000	803,000
right-of-use assets obtained in exchange for finance lease obligations	1,383,000	7,000	27,000	412,000	8,000	17,000	587,000	455,000	8,000	68,000	27,000	189,000	8,000	81,000	233,000			428,000
purchase of property and equipment funded through accounts payable and accrued liabilities	-109,000	1,727,000	63,000	417,000	-402,000	1,816,000	-93,000	-193,000	-313,000	1,781,000	446,000	-1,212,000	1,433,000	1,626,000	-2,509,000	2,603,000	52,000	2,184,000	-110,000	851,000	-1,036,000	1,702,000	-22,000	1,635,000	430,000	860,000	-341,000	252,000	699,000	427,000	-1,956,000	2,522,000	72,000	339,000		1,637,000	226,000	334,000
supplemental cash flow information:
cash paid for amounts included in the measurement of operating lease liabilities	5,567,000	5,564,000		5,420,000	5,676,000	5,337,000		5,169,000	5,110,000	4,706,000		4,559,000				2,300,000
cash paid for income taxes	7,083,000	5,996,000	6,307,000	4,824,000	8,418,000	1,125,000	2,528,000	1,083,000	1,533,000	1,413,000	416,000	346,000	359,000	1,798,000
inventory write-offs and write-downs
acquired in-process research and development							0																				0
proceeds from lease incentives											0	33,000	0	230,000	494,000
asset acquisition, net of cash acquired							0
proceeds from sales of marketable investments											0	0			0	0			709,000	0	0	7,188,000	2,046,000	0	1,682,000	1,018,000	-2,000	11,895,000			585,000	0	5,192,000	22,975,000	10,493,000	-26,458,000	28,462,000	500,000	2,838,000
payment of employee taxes related to vested common and restricted stock																							-2,416,000	-2,740,000	-11,281,000	-2,098,000													0
repurchase of common stock			1,000
supplemental disclosures of cash flow information:
fair value of common stock issued as consideration in connection with an asset acquisition
excise tax accrued on repurchase of common stock			-310,000
cash acquired in a business combination
fair value of common stock issued as consideration in connection with an acquisition
fair value of replacement options issued as consideration in connection with an acquisition
impairment of intangible asset																			0	0
proceeds from issuance of common stock upon underwritten public offering, net of issuance cost																			0	0
payment of acquisition-related obligations																			0	0	0	-683,000				-683,000	-50,000	0	-108,000	-4,323,000
consolidated net income												-2,271,000	-3,687,000	79,000		8,031,000	8,299,000	10,926,000		-9,876,000	-12,901,000	888,000
adjustments to reconcile consolidated net income to net cash from operating activities:
net decrease in cash and cash equivalents																		-14,038,000
lease payments made prior to commencement																							-2,555,000
proceeds from capital contribution from non-controlling interest																							300,000	0
loss on non-marketable equity investments																											0	920,000	1,230,000	951,000	727,000
asset acquisition (note 6), net of cash acquired
contributions to non-marketable investments																											0	-514,000
payment of obligations on debt and credit facilities																															-139,000
common shares issued as consideration in connection with a buyout agreement																											0	0	0	5,256,000
asset acquisition (note 6) and acquisition of business (note 5) related contingent and working capital liabilities
commercial paper																								21,000
u.s. agency and government sponsored securities																								-2,444,000
u.s. states and municipalities
corporate bonds																								-20,917,000
total																								-27,243,000
right-of-use assets obtained in exchange for lease obligations																						325,000
benefit from doubtful accounts																							141,000				730,000							145,000				11,000	95,000
change in fair value of contingent consideration																							-66,000				98,000	127,000	283,000	442,000
asset acquisition (note 3 and note 6) and acquisition of business (note 5), net of cash acquired
acquisition of intangible assets from a licensing agreement																															0
asset acquisition (note 3 and note 6) and acquisition of business (note 5) related contingent and working capital liabilities
indefinite-lived intangible assets related to licensed technology related contingent liabilities
u.s. treasury																								-2,375,000
u.s. agency securities and government sponsored securities
asset acquisition and acquisition of business (note 5), net of cash acquired
payment of asset acquisition-related and business acquisition-related obligations																								0
asset acquisition and acquisition of business (note 5) related contingent and working capital liabilities
(accretion of discount) amortization of premium on marketable investments																											-92,000
asset acquisition (note 3) and acquisition of business (note 5), net of cash acquired																											-500,000
asset acquisition (note 3) and acquisition of business (note 5) related contingent and working capital liabilities
licensing agreement related contingent liabilities
adjustments to reconcile consolidated net (loss) to net cash from operating activities:
purchase of marketable investments																												-35,474,000	-18,943,000	-42,552,000		-48,933,000	-45,607,000	-44,777,000		-17,560,000	-17,936,000	-9,531,000
payment of employee taxes related to vested restricted stock																												-2,176,000	-10,315,000	-3,530,000		-1,379,000	-7,101,000	-2,089,000		-178,000	-204,000	-1,642,000
asset acquisition
amortization of premium on marketable investments																														32,000	90,000	65,000	137,000	299,000	264,000	288,000	256,000	189,000
deposit payments for acquisition
net increase in cash and cash equivalents and restricted cash																													6,900,000	2,168,000
cash and cash equivalents and restricted cash—beginning of period																													0	50,637,000
cash and cash equivalents and restricted cash—end of period																													6,900,000	52,805,000
reconciliation of cash and cash equivalents and restricted cash:
cash and cash equivalents																													6,900,000	52,805,000
restricted cash
total cash and cash equivalent and restricted cash - end of period																													6,900,000	52,805,000
contributions towards non-marketable investments																														-352,000
issuance cost not yet paid																																		295,000
realized (gain) loss on marketable investments																																		-31,000	-5,000	-1,000
acquisition of a business, net of cash acquired																															0
purchase of non-marketable investments																															-135,000	-56,000
proceeds from issuance of common stock issued in initial public offering, net of issuance costs																																							-1,174,000
conversion of convertible preferred stock into common stock																																							0
acquisition-related contingent consideration and working capital adjustment liabilities																															1,170,000
licensing agreement related contingent consideration																															0
inventory write downs																																556,000	184,000	256,000	1,477,000	366,000	507,000	317,000	459,000
proceeds from issuance of common stock, net of issuance cost																																0	-298,000	106,563,000
change in restricted cash																																	-28,000	-1,686,000
loss on disposal of property and equipment																																			84,000	0	48,000	11,000	31,000
write off of note receivable																																							0
loss on minority investment
proceeds from issuance of preferred stock, net of issuance costs
repurchase of preferred stock
repayment of credit facility
repurchase of common stock and stock options
cash paid for interest
purchase of property and equipment funded through accounts payable																																							-57,000
excess tax benefit from stock-based compensation																																				-3,228,000	-2,863,000	-1,510,000	-333,000
benefit from (release of) doubtful accounts																																				80,000
deferred issuance costs not yet paid
(release of) benefit from sales returns
benefit from product warranty																																							100,000
payment of deferred issuance costs
benefit from sales returns																																						262,000	408,000
provision (release) for product warranty																																						-215,000
realized loss on marketable investments																																							0
release of valuation allowance
issuance of common stock to third parties
proceeds from credit facility

We provide you with 20 years of cash flow statements for Penumbra stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Penumbra stock. Explore the full financial landscape of Penumbra stock with our expertly curated income statements.

The information provided in this report about Penumbra stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.